NEW YORK (GenomeWeb News) – IntelligentMDx today said that it has gained ISO certification from Canadian authorities to develop and manufacture its molecular diagnostic tests at its facilities in Cambridge , Mass., where the firm is based.

IMDx said that it underwent an audit of its quality system to ISO 13485:2003 with the implementation of requirements from the Canadian Medical Devices Regulations. The accreditation was received from the Laboratoire national de métrologie et d'essais and will enable the firm to seek licenses to commercialize its tests in Canada.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: co-evolutionary signatures of insect hosts and bacterial symbionts, distinct transcript isoforms of high-grade ovarian cancer, and more.

Adam Rutherford discusses genetic genealogy at the Guardian.

Portions of the US 21st Century Cures Act are raising some safety concerns.

David Dobbs writes at Buzzfeed that genomics has delivered little on its promises.